|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.61 HKD | -3.96% |
|
+4.30% | +5.35% |
| 07-09 | Simcere Pharma's Acute Ischemic Stroke Included in National Essential Medicines List | MT |
| 06-15 | Simcere Pharma Gets China Nod for Tumor Drug Trial | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Stocks
- 2096 Stock
- Consensus Simcere Pharmaceutical Group Limited
- Estimates Revisions
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
